Onconetix (ONCO) Return on Sales (2023 - 2025)
Historic Return on Sales for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 28.93%.
- Onconetix's Return on Sales fell 195200.0% to 28.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.16%, marking a year-over-year decrease of 83600.0%. This contributed to the annual value of 23.25% for FY2024, which is 6166100.0% up from last year.
- As of Q3 2025, Onconetix's Return on Sales stood at 28.93%, which was down 195200.0% from 22.28% recorded in Q2 2025.
- Over the past 5 years, Onconetix's Return on Sales peaked at 118.62% during Q4 2023, and registered a low of 84.09% during Q1 2025.
- For the 3-year period, Onconetix's Return on Sales averaged around 5.16%, with its median value being 18.09% (2024).
- As far as peak fluctuations go, Onconetix's Return on Sales crashed by -1599700bps in 2024, and later tumbled by -19800bps in 2025.
- Onconetix's Return on Sales (Quarter) stood at 118.62% in 2023, then tumbled by -135bps to 41.35% in 2024, then soared by 30bps to 28.93% in 2025.
- Its last three reported values are 28.93% in Q3 2025, 22.28% for Q2 2025, and 84.09% during Q1 2025.